5 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Therapy - Drug Regimens ... Tuberculosis - IDSA ... Guidelines # ... #medications #pharmacology ... #IDSA #Guidelines
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... clinical practice guideline1 ... 5.2 and 5.4 #EBM ... #Management #Pharmacology ... #Medications #Pharmacotherapy
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... exacerbations. 2019 GOLD guidelines ... #Roflumilast #Indications ... #Pharmacology #
Taken from Dr Motov's work on a CERTA regime.
This is published in conjunction with the CERTA
work on a CERTA regime ... than just opioid medications ... a prescribing guideline ... #Management #Pharmacology ... PainSyndromes #Pathways #Table
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
prevent TB disease) Indications ... RAL-based ART regimen ... Please refer to the table ... Adolescent ARV Guidelines ... infections #HIVAIDS #pharmacology